- Stocks
- Healthcare
- NYSE: ZBH

Price (delayed)

$137.32

Market cap

$28.43B

P/E Ratio

686.6

Dividend/share

$0.96

EPS

$0.2

Enterprise value

$35.93B

The debt has declined by 15% since the previous quarter and by 6% year-on-year

The EPS has soared by 111% YoY but it has plunged by 89% from the previous quarter

The net income has surged by 110% year-on-year but it has dropped by 90% since the previous quarter

Zimmer Biomet Holdings's gross profit has decreased by 11% YoY and by 11% from the previous quarter

The revenue has contracted by 11% YoY and by 10% from the previous quarter

What are the main financial stats of ZBH

Market
Valuations
Earnings

Shares outstanding

207.05M

Market cap

$28.43B

Enterprise value

$35.93B

Price to earnings (P/E)

686.6

Price to book (P/B)

2.44

Price to sales (P/S)

4.04

EV/EBIT

N/A

EV/EBITDA

36.78

EV/Sales

5.11

Revenue

$7.03B

EBIT

-$37.3M

EBITDA

$976.8M

Free cash flow

$899.3M

Per share
Balance sheet
Liquidity

EPS

$0.2

Free cash flow per share

$4.35

Book value per share

$56.29

Revenue per share

$33.98

TBVPS

$37.37

Total assets

$23.65B

Total liabilities

$12B

Debt

$8.21B

Equity

$11.64B

Working capital

$2.55B

Debt to equity

0.71

Current ratio

2.18

Quick ratio

0.82

Net debt/EBITDA

7.67

Margins
Efficiency
Dividend

EBITDA margin

13.9%

Gross margin

71.1%

Net margin

0.5%

Operating margin

-0.6%

Return on assets

0.1%

Return on equity

0.3%

Return on invested capital

-0.3%

Return on capital employed

-0.2%

Return on sales

-0.5%

Dividend yield

0.7%

DPS

$0.96

Payout ratio

480%

How has the Zimmer Biomet Holdings stock price performed over time

How have Zimmer Biomet Holdings's revenue and profit performed over time

Revenue

$7.03B

Gross profit

$5B

Operating income

-$45.1M

Net income

$36.7M

Gross margin

71.1%

Net margin

0.5%

Zimmer Biomet Holdings's operating margin has shrunk by 200% YoY and by 114% QoQ

Zimmer Biomet Holdings's operating income has shrunk by 114% QoQ

The net margin has surged by 111% year-on-year but it has dropped by 90% since the previous quarter

The net income has surged by 110% year-on-year but it has dropped by 90% since the previous quarter

What is Zimmer Biomet Holdings stock price valuation

P/E

686.6

P/B

2.44

P/S

4.04

EV/EBIT

N/A

EV/EBITDA

36.78

EV/Sales

5.11

The EPS has soared by 111% YoY but it has plunged by 89% from the previous quarter

The stock's P/B is 11% above its 5-year quarterly average of 2.2 and 11% above its last 4 quarters average of 2.2

ZBH's equity is down by 2% since the previous quarter

ZBH's price to sales (P/S) is 26% higher than its 5-year quarterly average of 3.2 and 19% higher than its last 4 quarters average of 3.4

The revenue has contracted by 11% YoY and by 10% from the previous quarter

How efficient is Zimmer Biomet Holdings business performance

The ROS has plunged by 112% from the previous quarter and by 67% YoY

The ROIC has shrunk by 111% QoQ and by 50% YoY

Zimmer Biomet Holdings's return on equity has surged by 110% YoY but it has shrunk by 90% QoQ

The ROA has soared by 107% YoY but it has plunged by 93% from the previous quarter

What is ZBH's dividend history

DPS

$0.96

Dividend yield

0.7%

Payout ratio

480%

Recent dividends

How did Zimmer Biomet Holdings financials performed over time

The total assets is 97% higher than the total liabilities

The current ratio has soared by 83% YoY and by 29% from the previous quarter

ZBH's quick ratio has soared by 82% YoY but it is down by 11% QoQ

The debt is 30% smaller than the equity

The debt has declined by 15% since the previous quarter and by 6% year-on-year

The debt to equity has declined by 12% since the previous quarter and by 5% year-on-year

All financial data is based on trailing twelve months (TTM) periods - updated quarterly, unless otherwise specified.